Antony Pfaffle, Interim Chief Medical Officer at CorMedix Inc. (CRMD), sold 59,314 shares at $2.17 ($127K) on 2016-06-20, disclosed to the SEC on 2016-06-22.
Open-market sale of $127k CRMD by Interim Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.14 | 5,000 | $11K | 8.5% |
| 2 | $2.14 | 5,000 | $11K | 8.5% |
| 3 | $2.17 | 5,000 | $11K | 8.6% |
| 4 | $2.17 | 5,000 | $11K | 8.6% |
| 5 | $2.11 | 7,181 | $15K | 12.0% |
| 6 | $2.11 | 7,181 |
| $15K |
| 12.0% |
| 7 | $2.12 | 9,657 | $20K | 16.2% |
| 8 | $2.12 | 9,657 | $20K | 16.2% |
| 9 | $2.15 | 2,000 | $4K | 3.4% |
| 10 | $2.15 | 2,000 | $4K | 3.4% |
| 11 | $2.21 | 819 | $2K | 1.4% |
| 12 | $2.21 | 819 | $2K | 1.4% |
| Total | $2.13 avg | 59,314 | $127K | 100% |
| Filing → |
| CRMD | SELL | 2016-06-16 | $11K | — | Filing → |
| CRMD | SELL | 2016-06-14 | $12K | — | Filing → |
| CRMD | SELL | 2016-06-13 | $24K | — | Filing → |